Evidence map›Paper›PMID 25531321›Full record

ArticleOncogene2015

c-MYC is a radiosensitive locus in human breast cells.

M A Wade, N J Sunter, S E Fordham, A Long, D Masic, L J Russell, C J Harrison, V Rand, C Elstob, N Bown and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.Journal of experimental & clinical cancer research : CR · 2017
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

M A WadeNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
N J SunterNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
S E FordhamNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
A LongNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
D MasicNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
L J RussellNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
C J HarrisonNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
V RandNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
C ElstobNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
N BownNorthern Genetics Service, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
D RoweNorthern Genetics Service, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
C LoweNorthern Genetics Service, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
G CuthbertNorthern Genetics Service, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
S BennettNorthern Genetics Service, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
S CrosierNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
C M BaconNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
K OnelDepartment of Pediatrics, University of Chicago, Chicago, IL, USA.
K ScottDepartment of Biology, University of York, Heslington, York, UK.
D ScottDepartment of Histopathology, Harrogate and District NHS Foundation Trust, Harrogate District Hospital, Yorkshire, UK.
L B TravisDepartment of Radiation Oncology and Rubin Center for Cancer Survivorship, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.
F E B MayNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
J M AllanNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
Newcastle University · GBHarrogate and District NHS Foundation Trust · GBUniversity of Chicago · USUniversity of Rochester Medical Center · USUniversity of York · GB

Funding

Medical Research Council G0700035-1
6 · The paper itself

Abstract

Ionising radiation is a potent human carcinogen. Epidemiological studies have shown that adolescent and young women are at increased risk of developing breast cancer following exposure to ionising radiation compared with older women, and that risk is dose-dependent. Although it is well understood which individuals are at risk of radiation-induced breast carcinogenesis, the molecular genetic mechanisms that underlie cell transformation are less clear. To identify genetic alterations potentially responsible for driving radiogenic breast transformation, we exposed the human breast epithelial cell line MCF-10A to fractionated doses of X-rays and examined the copy number and cytogenetic alterations. We identified numerous alterations of c-MYC that included high-level focal amplification associated with increased protein expression. c-MYC amplification was also observed in primary human mammary epithelial cells following exposure to radiation. We also demonstrate that the frequency and magnitude of c-MYC amplification and c-MYC protein expression is significantly higher in breast cancer with antecedent radiation exposure compared with breast cancer without a radiation aetiology. Our data also demonstrate extensive intratumor heterogeneity with respect to c-MYC copy number in radiogenic breast cancer, suggesting continuous evolution at this locus during disease development and progression. Taken together, these data identify c-MYC as a radiosensitive locus, implicating this oncogenic transcription factor in the aetiology of radiogenic breast cancer.

Indexed as

Genes, mycBreastBreast NeoplasmsCell LineDNA Copy Number VariationsFemaleHodgkin DiseaseHumansNeoplasms, Radiation-InducedPolymorphism, Single NucleotideRadiation DosageRadiation Tolerance

Identifiers

PMID25531321
PMCPMC4391966
OpenAlexW2105184570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.